Pemetrexed/Carboplatin: clinical trials recruiting now
3
Recruiting trials
6
Conditions studied
17
US states with sites
13
Countries
Phase breakdown
Phase 2 3
Conditions being studied
| Condition | Trials |
|---|---|
| Lung cancer · Pemetrexed/Carboplatin for Lung cancer | 3 |
| Adjuvant Drug Therapy | 1 |
| EGFR | 1 |
| First-line Advanced NSCLC Patients | 1 |
| NSCLC | 1 |
| Non-small Cell Lung Cancer | 1 |
Recruiting trials involving Pemetrexed/Carboplatin
- A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer（NSCLC） Patients
- Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
- Sequential Chemotherapy With Befotertinib in Non-Small Cell Lung Cancer (NSCLC) Patients With Resistance to Third-Generation EGFR-TKI
Common questions
How many recruiting trials involve Pemetrexed/Carboplatin?
3 recruiting trials across 6 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.